These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29217651)

  • 1. Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes.
    Zaharieva E; Kamenov Z; Velikova T; Tsakova A; El-Darawish Y; Okamura H
    Endocr Connect; 2018 Jan; 7(1):179-185. PubMed ID: 29217651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults.
    Napoli N; Strollo R; Defeudis G; Leto G; Moretti C; Zampetti S; D'Onofrio L; Campagna G; Palermo A; Greto V; Manfrini S; Hawa MI; Leslie RD; Pozzilli P; Buzzetti R;
    J Clin Endocrinol Metab; 2018 May; 103(5):1921-1928. PubMed ID: 29506222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian Population.
    Zaharieva ET; Velikova TV; Tsakova AD; Kamenov ZA
    J Diabetes Res; 2017; 2017():9016148. PubMed ID: 28573146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA).
    Hjort R; Alfredsson L; Andersson T; Carlsson PO; Grill V; Groop L; Martinell M; Rasouli B; Storm P; Tuomi T; Carlsson S
    Diabetes Metab; 2017 Dec; 43(6):536-542. PubMed ID: 28669512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density spectrum in individuals with type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes.
    Hu Y; Li X; Yan X; Huang G; Dai R; Zhou Z
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3390. PubMed ID: 32748546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes.
    Singh K; Martinell M; Luo Z; Espes D; Stålhammar J; Sandler S; Carlsson PO
    Clin Exp Immunol; 2019 Jul; 197(1):64-73. PubMed ID: 30843600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes and clinical significance of serum proteinase 3 in latent autoimmune diabetes in adults].
    Yu Y; Liu LL; Xiao XY; Wang YD; Xu AM; Tu YT; Liu LJ; Xiao Y; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2660-2664. PubMed ID: 31505715
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA).
    Martinell M; Dorkhan M; Stålhammar J; Storm P; Groop L; Gustavsson C
    J Diabetes Complications; 2016; 30(8):1456-1461. PubMed ID: 27593902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestation and islet β-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes.
    Liang H; Cheng Y; Tang W; Cui Q; Yuan J; Huang G; Yang L; Zhou Z
    Acta Diabetol; 2019 Nov; 56(11):1225-1230. PubMed ID: 31367990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following
    Badal D; Kumar R; Paul M; Dayal D; Bhansali A; Bhadada SK; Kumar R; Sachdeva N
    Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).
    Maddaloni E; Coleman RL; Pozzilli P; Holman RR
    Diabetes Obes Metab; 2019 Sep; 21(9):2115-2122. PubMed ID: 31099472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes.
    Tsiavou A; Degiannis D; Hatziagelaki E; Koniavitou K; Raptis SA
    J Interferon Cytokine Res; 2004 Jul; 24(7):381-7. PubMed ID: 15296648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity of latent autoimmune diabetes in adults identified by body composition analysis.
    Pes GM; Delitala AP; Delitala G; Errigo A; Costantino S; Fanciulli G
    Diabetol Metab Syndr; 2014; 6():128. PubMed ID: 25960773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a distinct phenotype of elderly latent autoimmune diabetes in adults: LADA China Study 8.
    Niu X; Luo S; Li X; Xie Z; Xiang Y; Huang G; Lin J; Yang L; Liu Z; Wang X; Leslie RD; Zhou Z
    Diabetes Metab Res Rev; 2019 Jan; 35(1):e3068. PubMed ID: 30160000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes.
    Mishra R; Chesi A; Cousminer DL; Hawa MI; Bradfield JP; Hodge KM; Guy VC; Hakonarson H; ; Mauricio D; Schloot NC; Yderstræde KB; Voight BF; Schwartz S; Boehm BO; Leslie RD; Grant SFA
    BMC Med; 2017 Apr; 15(1):88. PubMed ID: 28438156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased spontaneous CCL2 (MCP-1) and CCL5 (RANTES) secretion in vitro in LADA compared to type 1 diabetes and type 2 diabetes: Action LADA 14.
    Ooms M; Strom A; Strassburger K; Menart B; Leslie RD; Schloot NC
    Diabetes Metab Res Rev; 2021 Oct; 37(7):e3431. PubMed ID: 33369072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.
    Pham MN; Hawa MI; Pfleger C; Roden M; Schernthaner G; Pozzilli P; Buzzetti R; Scherbaum WA; Seissler J; Kolb H; Hunter S; Leslie RD; Schloot NC;
    Diabetologia; 2011 Jul; 54(7):1630-8. PubMed ID: 21347621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6.
    Strom A; Menart B; Simon MC; Pham MN; Kolb H; Roden M; Pozzilli P; Leslie RD; Schloot NC
    Cytokine; 2012 May; 58(2):148-51. PubMed ID: 22305546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower mortality and cardiovascular event rates in patients with Latent Autoimmune Diabetes In Adults (LADA) as compared with type 2 diabetes and insulin deficient diabetes: A cohort study of 4368 patients.
    Wod M; Thomsen RW; Pedersen L; Yderstraede KB; Beck-Nielsen H; Højlund K
    Diabetes Res Clin Pract; 2018 May; 139():107-113. PubMed ID: 29518492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.